Welcome to LookChem.com Sign In|Join Free

CAS

  • or

118055-06-4

Post Buying Request

118055-06-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

118055-06-4 Usage

General Description

Ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylate is a synthetic intermediate used in the manufacture of various chemical products. Its chemical formula is C12H16N2O2. This chemical compound falls under the category of pyrazolopyridines, which are organic compounds featuring a pyrazolopyridine, where a pyridine is fused to a pyrazole. Due to its specific structure, this chemical compound is used in the synthesis of more complex chemical structures in pharmaceuticals and other chemical industries. Apart from its use as a synthetic intermediate, there is limited information on other characteristics or applications of Ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylate.

Check Digit Verification of cas no

The CAS Registry Mumber 118055-06-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,0,5 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 118055-06:
(8*1)+(7*1)+(6*8)+(5*0)+(4*5)+(3*5)+(2*0)+(1*6)=104
104 % 10 = 4
So 118055-06-4 is a valid CAS Registry Number.

118055-06-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl 4,5,6,7-tetrahydropyrazolo<1,5-a>pyridine-3-yl-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118055-06-4 SDS

118055-06-4Relevant articles and documents

Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors

Xie, Hongming,Lin, Xinglong,Zhang, Yingjun,Tan, Fuxing,Chi, Bo,Peng, Zhihong,Dong, Wanrong,An, Delie

, (2020/10/06)

We report herein the synthesis of novel ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors and the evaluation of pharmaceutical activity against five cancer cell lines (MDA-MB-231, BXPC-3, NCI-H1975, DU145 and 786O). Generally, the majority of compounds displayed strong anti-FAK enzymatic potencies (IC50 1 nM) and could effectively inhibit several class of cancer cell lines within the concentration of 3 μM in comparison with GSK2256098 as a reference. Among them, compound 4o is considered to be the most effective due to high sensitivity in antiproliferation. In culture, 4o could not only inhibit FAK Y397 phosphorylation in MDA-MB-231 cell line, but also trigger apoptosis in a dose-dependent manner. Furthermore, computational docking analysis also suggested that 4o and TAE-226 displayed the similar interaction with FAK kinase domain.

Focal adhesion kinase inhibitor and use

-

, (2019/01/08)

The invention belongs to the field of medicines, relates to a focal adhesion kinase inhibitor and use, in particular relates to a novel focal adhesion kinase inhibitor compound, or stereoisomers, geometric isomers, tautomers, oxynitrides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof, further relates to the use of the compound and pharmaceutical compositions as medicines, in particular the use of the compound and pharmaceutical compositions in manufacture of medicines for treatment or prevention of cancer, pulmonary hypertension, and pathological angiogenesis-related diseases.

Practical radical cyclizations with arylboronic acids and trifluoroborates

Lockner, Jonathan W.,Dixon, Darryl D.,Risgaard, Rune,Baran, Phil S.

supporting information; experimental part, p. 5628 - 5631 (2011/12/03)

Practical radical cyclizations using organoboronic acids and trifluoroborates take place in water, open to air, and in a scalable fashion employing catalytic silver nitrate and stoichiometric potassium persulfate. Both Pschorr-type cyclizations and tandem radical cyclization/trap cascades are described, illustrating the utility of these mild conditions for the generation of polycyclic scaffolds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 118055-06-4